Rubric Capital Management LP Roivant Sciences Ltd. Transaction History

Rubric Capital Management LP

  • $6.05 Billion
  • Q4 2024

A detailed history of Rubric Capital Management LP transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Rubric Capital Management LP holds 20,000,000 shares of ROIV stock, worth $214 Million. This represents 3.91% of its overall portfolio holdings.

Number of Shares
20,000,000
Previous 22,400,000 10.71%
Holding current value
$214 Million
Previous $258 Million 8.47%
% of portfolio
3.91%
Previous 7.2%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$11.16 - $12.71 $26.8 Million - $30.5 Million
-2,400,000 Reduced 10.71%
20,000,000 $237 Million
Q3 2024

Nov 13, 2024
SELL
$10.17 - $12.5 $6.1 Million - $7.5 Million
-600,000 Reduced 2.61%
22,400,000 $258 Million
Q2 2024

Aug 13, 2024
BUY
$10.36 - $11.74 $31.1 Million - $35.2 Million
3,000,000 Added 15.0%
23,000,000 $243 Million
Q1 2024

May 10, 2024
BUY
$9.87 - $11.8 $9.87 Million - $11.8 Million
1,000,000 Added 5.26%
20,000,000 $211 Million
Q4 2023

Feb 13, 2024
BUY
$8.38 - $11.58 $71.2 Million - $98.4 Million
8,500,000 Added 80.95%
19,000,000 $213 Million
Q3 2023

Nov 14, 2023
BUY
$9.76 - $13.19 $68 Million - $91.8 Million
6,963,562 Added 196.91%
10,500,000 $123 Million
Q2 2023

Aug 11, 2023
SELL
$7.09 - $10.08 $14.6 Million - $20.8 Million
-2,063,562 Reduced 36.85%
3,536,438 $35.6 Million
Q1 2023

May 12, 2023
BUY
$6.92 - $9.98 $18 Million - $25.9 Million
2,600,000 Added 86.67%
5,600,000 $41.3 Million
Q4 2022

Feb 10, 2023
BUY
$3.36 - $7.99 $10.1 Million - $24 Million
3,000,000 New
3,000,000 $24 Million

Others Institutions Holding ROIV

# of Institutions
329
Shares Held
505M
Call Options Held
573K
Put Options Held
739K
View Full List

About Roivant Sciences Ltd.

ROIV Quotes by TradingView
  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $7.52B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Rubric Capital Management LP Portfolio

Follow Rubric Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rubric Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Rubric Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email